VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma.
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma. J Clin Invest. 2015 Apr; 125(4):1459-70.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Doxycycline
Drug Resistance, Neoplasm
Gene Expression Profiling
Humans
Imidazoles
Melanoma
Melanoma, Experimental
Mice
Neoplasm Proteins
Oximes
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf
PTEN Phosphohydrolase
Tamoxifen
Transgenes
authors with profiles
GORDON B MILLS
LAWRENCE KWONG
JENNIFER WARGO